Commentary: Hatch should help generic drugs get to market
Lower drug prices depend upon the timely entry of generic competitors at the conclusion of a drug’s patent life. Current legislation, moving through Congress, would limit the ability for generic manufacturers to compete with patent-protected pharmaceutical companies.
Community input sought in New Haven diversion program
Nearly a year after the city implemented its harm reduction program, LEAD, it’s reaching out to involve the community in the effort. Sophie Wheelock, a master's of public health candidate t at the Yale School of Public Health worked on a report presented to the community in September.